|
1
|
Buskwofie A, David-West G and Clare CA: A
review of cervical cancer: Incidence and disparities. J Natl Med
Assoc. 112:229–232. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Malik KI, Aliyu DU, Abubakar BJ, Lukman Y,
Sale KA, Alkali BH, Saidu A, Bala DA, Umoru A, Lawal N and Abubakar
AI: Identification of high-risk human papillomavirus isolates
circulating in Nigeria and phylogenetic analysis based on the virus
essential protein. Indian J Gynecol Oncol. 19(87)2021.
|
|
3
|
Singh D, Vignat J, Lorenzoni V, Eslahi M,
Ginsburg O, Lauby-Secretan B, Arbyn M, Basu P, Bray F and
Vaccarella S: Global estimates of incidence and mortality of
cervical cancer in 2020: A baseline analysis of the WHO global
cervical cancer elimination initiative. Lancet Glob Heal.
11:e197–e206. 2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Vu M, Yu J, Awolude OA and Chuang L:
Cervical cancer worldwide. Curr Probl Cancer. 42:457–465.
2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Collins Y, Holcomb K, Chapman-Davis E,
Khabele D and Farley JH: Gynecologic cancer disparities: A report
from the health disparities taskforce of the society of gynecologic
oncology. Gynecol Oncol. 133:353–361. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Siegel RL, Kratzer TB, Giaquinto AN, Sung
H and Jemal A: Cancer statistics, 2025. CA Cancer J Clin. 75:10–45.
2025.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wu J, Jin Q, Zhang Y, Ji J, Li J, Liu X,
Duan H, Feng Z, Liu Y, Zhang Y, et al: Global burden of cervical
cancer: Current estimates, temporal trend and future projections
based on the GLOBOCAN 2022. J Natl Cancer Cent. 23:1–24. 2025.
|
|
9
|
zur Hausen H: Papillomaviruses and cancer:
From basic studies to clinical application. Nat Rev Cancer.
2:342–350. 2002.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Akinlotan M, Bolin JN, Helduser J,
Ojinnaka C, Lichorad A and McClellan D: Cervical cancer screening
barriers and risk factor knowledge among uninsured women. J
Community Health. 42:770–778. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Johnson CA, James D, Marzan A and Armaos
M: Cervical cancer: An overview of pathophysiology and management.
Semin Oncol Nurs. 35:166–174. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kabir IM, Dutsinma UA, Bala JA, Yusuf L,
Abubakar SD, Kumurya AS, Bulama HA, Bello ZM and Aliyu IA: The need
for therapeutic hpv vaccines as a means of curbing the menace of
cervical cancer. Indian J Gynecol Oncol. 19(96)2021.
|
|
13
|
Jenkin D: A brief history of cervical
cancer. INC, 2019.
|
|
14
|
Yousefi Z, Aria H, Ghaedrahmati F,
Bakhtiari T, Azizi M, Bastan R, Hosseini R and Eskandari N: An
update on human papilloma virus vaccines: History, types,
protection, and efficacy. Front Immunol. 12(805695)2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Jain MA and Limaiem F: Human
Papillomavirus and Related Diseases From Bench to Bedside A
Diagnostic and Preventive Perspective. Treasure Island, FL,
2023.
|
|
16
|
Broeck DV: Human papillomavirus and
related diseases-from bench to bedside. Broeck DV (ed). IntechOpen,
p336, 2012.
|
|
17
|
Herfs M, Hubert P, Moutschen M and
Delvenne P: Mucosal junctions: Open doors to HPV and HIV
infections? Trends Microbiol. 19:114–120. 2011.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yuan F, Auborn K and James C: Altered
growth and viral gene expression in human papillomavirus type
16-containing cancer cell lines treated with progesterone. Cancer
Invest. 17:19–29. 1999.PubMed/NCBI
|
|
19
|
Jing Y, Wang T, Chen Z, Ding X, Xu J, Mu
X, Cao M and Chen H: Phylogeny and polymorphism in the long control
regions E6, E7, and L1 of HPV type 56 in women from Southwest
China. Mol Med Rep. 17:7131–7141. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kuguyo O, Tsikai N, Thomford NE, Magwali
T, Madziyire MG, Nhachi CFB, Matimba A and Dandara C: Genetic
susceptibility for cervical cancer in African populations: What are
the host genetic drivers? OMICS. 22:468–483. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhang Y, Fan S, Meng Q, Ma Y, Katiyar P,
Schlegel R and Rosen EM: BRCA1 interaction with human
papillomavirus oncoproteins. J Biol Chem. 280:33165–33177.
2005.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhou X, Han S, Wang S, Chen X, Dong J, Shi
X, Xia Y, Wang X, Hu Z and Shen H: Polymorphisms in HPV E6/E7
protein interacted genes and risk of cervical cancer in Chinese
women: A case-control analysis. Gynecol Oncol. 114:327–331.
2009.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Bodily J and Laimins AL: Persistence of
human papillomavirus infection: Keys to malignant progression.
Trends Microbiol. 19:33–39. 2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Baseman JG and Koutsky LA: The
epidemiology of human papillomavirus infections. J Clin Virol.
32:16–24. 2005.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Münger K, Baldwin A, Edwards KM, Hayakawa
H, Nguyen CL, Owens M, Grace M and Huh K: Mechanisms of human
papillomavirus-induced oncogenesis. J Virol. 78:11451–11460.
2004.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Schiffman M and Wentzensen N: Human
papillomavirus (HPV) infection and the multi-stage carcinogenesis
of cervical cancer introduction and historic context. Cancer
Epidemiol Biomarkers Prev. 22:553–560. 2013.
|
|
27
|
Yadav C, Yadav R, Chabbra R, Nanda S,
Ranga S, Kadian L and Ahuja P: Overview of genetic and epigenetic
regulation of human papillomavirus and apoptosis in cervical
cancer. Apoptosis. 28:683–701. 2023.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Smola S, Trimble C and Stern PL: Human
papillomavirus-driven immune deviation: Challenge and novel
opportunity for immunotherapy. Ther Adv Vaccines. 5:69–82.
2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Gutiérrez-Hoya A and Soto-Cruz I: NK cell
regulation in cervical cancer and strategies for immunotherapy.
Cells. 10(3104)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Tamoutounour S, Han SJ, Deckers J,
Constantinides MG, Hurabielle C, Harrison OJ, Bouladoux N, Linehan
JL, Link VM, Vujkovic-Cvijin I, et al: Keratinocyte-intrinsic MHCII
expression controls microbiota-induced Th1 cell responses. Proc
Natl Acad Sci USA. 116:23643–23652. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Manzo-Merino J, Del-Toro-Arreola S,
Rocha-Zavaleta L, Peralta-Zaragoza Ó, Jiménez-Lima R and
Madrid-Marina V: Immunology of cervical cancer. Rev Invest Clin.
72:188–197. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Stanley MA: Immune responses to human
papilloma viruses. Indian J Med Res. 130:266–276. 2009.PubMed/NCBI
|
|
33
|
Stanley M: Immunobiology of HPV and HPV
vaccines. Gynecol Oncol. 109 (Suppl 2):S15–S21. 2008.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Tindle RW: Cervical Cancer. StatPearls
Publishing, Treasure Island, FL, pp1-7, 2002.
|
|
35
|
Doorbar J, Egawa N, Griffin H, Kranjec C
and Murakami I: Human papillomavirus molecular biology and disease
association. Rev Med Virol. 25 (Suppl 1):S2–S23. 2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Siddiqa A, Sims-Mourtada JC, Guzman-Rojas
L, Rangel R, Guret C, Madrid-Marina V, Sun Y and Martinez-Valdez H:
Regulation of CD40 and CD40 ligand by the AT-hook transcription
factor AKNA. Nature. 410:383–387. 2001.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Garcia-Iglesias T, Del Toro-Arreola A,
Albarran-Somoza B, Del Toro-Arreola S, Sanchez-Hernandez PE,
Ramirez-Dueñas MG, Balderas-Peña LM, Bravo-Cuellar A,
Ortiz-Lazareno PC and Daneri-Navarro A: Low NKp30, NKp46 and NKG2D
expression and reduced cytotoxic activity on NK cells in cervical
cancer and precursor lesions. BMC Cancer. 9(186)2009.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Sasson IM, Haley NJ, Hoffmann D, Wynder
EL, Hellberg D and Nilsson S: Cigarette smoking and neoplasia of
the uterine cervix: Smoke constituents in cervical mucus. N Engl J
Med. 312:315–316. 1985.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Roteli-Martins CM, Panetta K, Alves VA,
Siqueira SA, Syrjänen KJ and Derchain SF: Cigarette smoking and
high-risk HPV DNA as predisposing factors for high-grade cervical
intraepithelial neoplasia (CIN) in young Brazilian women. Acta
Obstet Gynecol Scand. 77:678–682. 1998.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Stumbar SE, Stevens M and Feld Z: Cervical
cancer and its precursors: A preventative approach to screening,
diagnosis, and management. Prim Care. 46:117–134. 2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
International Collaboration of
Epidemiological Studies of Cervical Cancer. Comparison of risk
factors for invasive squamous cell carcinoma and adenocarcinoma of
the cervix: Collaborative reanalysis of individual data on 8,097
women with squamous cell carcinoma and 1,374 women with
adenocarcinoma from 12 epidemiological studies. Int J Cancer.
120:885–891. 2007.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Burd EM: Human papillomavirus and cervical
cancer. Clin Microbiol Rev. 16:1–17. 2003.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Olusola P, Banerjee HN, Philley JV and
Dasgupta S: Human papilloma virus-associated cervical cancer and
health disparities. Cells. 8(622)2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Fowler JR, Maani EV, Dunton CJ and Jack
BW: Cervical Cancer. StatPearls Publishing, Treasure Island, FL,
2023.
|
|
45
|
Burness JV, Schroeder JM and Warren JB:
Cervical colposcopy: Indications and risk assessment. Am Fam
Physician. 102:39–48. 2020.PubMed/NCBI
|
|
46
|
Sachan P, Singh M, Patel M and Sachan R: A
study on cervical cancer screening using pap smear test and
clinical correlation. Asia Pac J Oncol Nurs. 5:337–341.
2018.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Turinetto M, Valsecchi AA, Tuninetti V,
Scotto G, Borella F and Valabrega G: Immunotherapy for cervical
cancer: Are we ready for prime time? Int J Mol Sci.
23(3559)2022.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Lazo PA: The molecular genetics of
cervical carcinoma. Br J Cancer. 80:2008–2018. 1999.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Mezache L, Paniccia B, Nyinawabera A and
Nuovo GJ: Enhanced expression of PD L1 in cervical intraepithelial
neoplasia and cervical cancers. Mod Pathol. 28:1594–1602.
2015.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Francisco LM, Salinas VH, Brown KE,
Vanguri VK, Freeman GJ, Kuchroo VK and Sharpe AH: PD-L1 regulates
the development, maintenance, and function of induced regulatory T
cells. J Exp Med. 206:3015–3029. 2009.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Jenkins RW, Barbie DA and Flaherty KT:
Mechanisms of resistance to immune checkpoint inhibitors. Br J
Cancer. 118:9–16. 2018.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Kakotkin VV, Semina EV, Zadorkina TG and
Agapov MA: Prevention strategies and early diagnosis of cervical
cancer: Current state and prospects. Diagnostics (Basel).
13(610)2023.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Mavundza EJ, Mmotsa TM and Ndwandwe D:
Human papillomavirus (HPV) trials: A cross-sectional analysis of
clinical trials registries. Hum Vaccin Immunother.
20(2393481)2024.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Saslow D, Andrews KS, Manassaram-Baptiste
D, Smith RA and Fontham ETH: American Cancer Society Guideline
Development Group. Human papillomavirus vaccination 2020 guideline
update: American cancer society guideline adaptation. CA Cancer J
Clin. 70:274–280. 2020.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Eun TJ and Perkins RB: Screening for
cervical cancer. Med Clin North Am. 104:1063–1078. 2020.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Pardini B, De Maria D, Francavilla A, Di
Gaetano C, Ronco G and Naccarati A: MicroRNAs as markers of
progression in cervical cancer: A systematic review. BMC Cancer.
18(696)2018.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Gu Y, Feng X, Jin Y, Liu Y, Zeng L, Zhou D
and Feng Y: Upregulation of miRNA-10a-5p promotes tumor progression
in cervical cancer by suppressing UBE2I signaling. J Obstet
Gynaecol. 43(2171283)2023.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Lev Maor G, Yearim A and Ast G: The
alternative role of DNA methylation in splicing regulation. Trends
Genet. 31:274–280. 2015.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Boland CR: Non-coding RNA: It's not junk.
Dig Dis Sci. 62:1107–1109. 2017.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Gao P and Zheng J: High-risk HPV
E5-induced cell fusion: A critical initiating event in the early
stage of HPV-associated cervical cancer. Virol J.
7(238)2010.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Hasan UA, Bates E, Takeshita F, Biliato A,
Accardi R, Bouvard V, Mansour M, Vincent I, Gissmann L, Iftner T,
et al: TLR9 expression and function is abolished by the cervical
cancer-associated human papillomavirus type 16. J Immunol.
178:3186–3197. 2007.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Howie HL, Katzenellenbogen RA and Galloway
DA: Papillomavirus E6 proteins. Bone. 23:1–7. 2008.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Huh KW, DeMasi J, Ogawa H, Nakatani Y,
Howley PM and Münger K: Association of the human papillomavirus
type 16 E7 oncoprotein with the 600-kDa retinoblastoma
protein-associated factor, p600. Proc Natl Acad Sci USA.
102:11492–11497. 2005.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Zerfass K, Schulze A, Spitkovsky D,
Friedman V, Henglein B and Jansen-Dürr P: Sequential activation of
cyclin E and cyclin A gene expression by human papillomavirus type
16 E7 through sequences necessary for transformation. J Virol.
69:6389–6399. 1995.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Eichten A, Rud DS, Grace M, Piboonniyom
SO, Zacny V and Münger K: Molecular pathways executing the ‘trophic
sentinel’ response in HPV-16 E7-expressing normal human diploid
fibroblasts upon growth factor deprivation. Virology. 319:81–93.
2004.PubMed/NCBI View Article : Google Scholar
|
|
66
|
McLaughlin-Daurbin ME: Oncogenic
activities of human papillomaviruses margaret. Virus Res.
71:3831–3840. 2014.
|
|
67
|
Spardy N, Duensing A, Charles D, Haines N,
Nakahara T, Lambert PF and Duensing S: The human papillomavirus
type 16 E7 oncoprotein activates the fanconi anemia (FA) pathway
and causes accelerated chromosomal instability in FA cells. J
Virol. 81:13265–13270. 2007.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Chen XF and Liu Y: MicroRNA-744 inhibited
cervical cancer growth and progression through apoptosis induction
by regulating Bcl-2. Biomed Pharmacother. 81:379–387.
2016.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Mou Z, Xu X, Dong M and Xu J:
MicroRNA-148b acts as a tumor suppressor in cervical cancer by
inducing G1/S-Phase cell cycle arrest and apoptosis in a
caspase-3-dependent manner. Med Sci Monit. 22:2809–2815.
2016.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Liu S, Zhang P, Chen Z, Liu M, Li X and
Tang H: MicroRNA-7 downregulates XIAP expression to suppress cell
growth and promote apoptosis in cervical cancer cells. FEBS Lett.
587:2247–2253. 2013.PubMed/NCBI View Article : Google Scholar
|
